Exclusive patent, know-how and technology license to practice, use, have used, make, have made, develop, have developed, import, have imported, offer, have offered, sell, have sold, market, have marketed, distribute, have distributed and sublicense products based on compositions and methods to elicit Th1 immune response that are liposomal cancer vaccines, including BLP25 containing a synthetic 25 amino acid sequence of the MUC-1 cancer mucin.